The use of imatinib with ipilimumab induced tumor clearance in a spontaneous model of GIST and immune-stimulation strongly synergised with the c-Kit inhibitor dasatinib to eradicate P815 c-Kit mutant mastocytomas in treated mice [22, 23]. The gene discussed is KIT; the disease is neoplasm.